A trial to evaluate the efficacy of 8 weeks Ledipasvir/Sofosbuvir therapy among non-cirrhotic, treatment naïve patients with genotype 1 infection.
Latest Information Update: 12 May 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 12 May 2016 New trial record
- 17 Apr 2016 Results presented at The International Liver Congress 2016